by StepChange Innovations GmbH
Login Status
You are not logged in.
Categories
Newsletter
Receive abstracts of new posts by e-mail
* = required field
Sponsored Ads

patents

Indian government forces Bayer to accept generic Nexavar competition – FiercePharma

India has invoked its compulsory licensing rules for the first time to make and sell a version of Bayer's cancer drug Nexavar despite the fact that Nexavar is still on patent. We think this is quite a significant development. What does it mean for ROI of big pharma companies R&D ? What does it mean for IP integrity for doing business in India ?
Continue reading
Sponsored Ads
Archives
Images: © Fotolia
Calendar
June 2017
M T W T F S S
« Feb    
 1234
567891011
12131415161718
19202122232425
2627282930  

Copyright © 2013. All Rights Reserved.